These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 2321996)

  • 41. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
    Roush GC; Barnhill RL
    Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Dysplastic nevus syndrome with familial melanoma (type D2)].
    Casanova JM; Panadés MJ; Ramos J; Salvatella N
    Med Clin (Barc); 1989 Mar; 92(10):382-4. PubMed ID: 2716387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi.
    Barnhill RL; Roush GC; Duray PH
    Hum Pathol; 1990 Jan; 21(1):51-8. PubMed ID: 2295508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dysplastic melanocytic nevi: quantitative ultrastructural investigation comparing intraepidermal melanocytes of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and normal skin].
    Seki Y; Fitzpatrick TB; Rhodes AR
    Nihon Hifuka Gakkai Zasshi; 1988 Oct; 98(11):1093-103. PubMed ID: 3225938
    [No Abstract]   [Full Text] [Related]  

  • 47. Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi.
    Touab M; Arumi-Uría M; Barranco C; Bassols A
    Am J Clin Pathol; 2003 Apr; 119(4):587-93. PubMed ID: 12710131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe architectural disorder is a potential pitfall in the diagnosis of small melanocytic lesions.
    Torres-Cabala CA; Plaza JA; Diwan AH; Prieto VG
    J Cutan Pathol; 2010 Aug; 37(8):860-5. PubMed ID: 19614731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pagetoid melanocytosis: tease or tocsin?
    Stern JB; Haupt HM
    Semin Diagn Pathol; 1998 Aug; 15(3):225-9. PubMed ID: 9711673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo confocal microscopy for detection and grading of dysplastic nevi: a pilot study.
    Pellacani G; Farnetani F; Gonzalez S; Longo C; Cesinaro AM; Casari A; Beretti F; Seidenari S; Gill M
    J Am Acad Dermatol; 2012 Mar; 66(3):e109-21. PubMed ID: 21742408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus.
    King R; Page RN; Googe PB; Mihm MC
    Mod Pathol; 2005 Oct; 18(10):1397-401. PubMed ID: 15976811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo optical properties of melanocytic skin lesions: common nevi, dysplastic nevi and malignant melanoma.
    Zonios G; Dimou A; Carrara M; Marchesini R
    Photochem Photobiol; 2010; 86(1):236-40. PubMed ID: 19845538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Clark/dysplastic" nevi with florid fibroplasia associated with pseudomelanomatous features.
    Ko CJ; Bolognia JL; Glusac EJ
    J Am Acad Dermatol; 2011 Feb; 64(2):346-51. PubMed ID: 21238828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The limited specificity of histological examination in the diagnosis of dysplastic nevi.
    Rabkin MS
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():20-3. PubMed ID: 18976415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The dysplastic nevus. Clinical and pathologic features.
    Friedman RJ; Heilman ER; Rigel DS; Kopf AW
    Dermatol Clin; 1985 Apr; 3(2):239-49. PubMed ID: 3830487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dysplastic nevi.
    Farber MJ; Heilman ER; Friedman RJ
    Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ideas in pathology. Malignant melanoma in situ: the evolution of a concept.
    Dubow BE; Ackerman AB
    Mod Pathol; 1990 Nov; 3(6):734-44. PubMed ID: 2263599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Grading of atypia in nevi: correlation with melanoma risk.
    Arumi-Uria M; McNutt NS; Finnerty B
    Mod Pathol; 2003 Aug; 16(8):764-71. PubMed ID: 12920220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.